Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank31
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-33.40M
Near historical average
Percentile
P31
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-32.11M
Historical baseline
PeriodValueYoY Change
TTM$-33.40M+0.2%
2024$-33.46M-21.6%
2023$-27.53M+13.0%
2022$-31.63M-21.2%
2021$-26.09M-36.8%
2020$-19.07M+54.2%
2019$-41.62M-75.7%
2018$-23.68M-16.4%
2017$-20.34M+68.4%
2016$-64.32M-